Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) EBITDA: 2018-2020

Historic EBITDA for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $277.1 million.

  • Genmab A's EBITDA rose 370.36% to $135.01 in Q2 2021 from the same period last year, while for Jun 2021 it was $278.86, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $277.1 million for FY2020, which is 22.66% up from last year.
  • Per Genmab A's latest filing, its EBITDA stood at $277.1 million for FY2020, which was up 22.66% from $225.9 million recorded in FY2019.
  • Genmab A's 5-year EBITDA high stood at $277.1 million for FY2020, and its period low was $163.9 million during FY2018.
  • Over the past 3 years, Genmab A's median EBITDA value was $225.9 million (recorded in 2019), while the average stood at $222.3 million.
  • Data for Genmab A's EBITDA shows a peak YoY soared of 37.85% (in 2019) over the last 5 years.
  • Genmab A's EBITDA (Yearly) stood at $163.9 million in 2018, then skyrocketed by 37.85% to $225.9 million in 2019, then rose by 22.66% to $277.1 million in 2020.